Miyahara S, Takahashi H, Tomimaru Y, Kobayashi S, et al. Response to the letter to the editor: "Refining the prognostic utility of CA19-9 in neoadjuvant therapy for pancreatic cancer: Emphasizing serial monitoring and subgroup differentiation". Pancreatology 2025 Sep 30:S1424-3903(25)00642-8. doi: 10.1016/j.pan.2025.
PMID: 41087239